Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TREVENA INC | Acting CEO, Director | Common Stock | 23.9K | $35.1K | $1.47 | Oct 8, 2024 | Direct |
Sesen Bio, Inc. | Director | Common Stock | 40K | $23.5K | $0.59 | Jun 22, 2022 | Direct |
Nabriva Therapeutics plc | Director | Ordinary Shares | 9.93K | $14.9K | $1.50 | Aug 1, 2022 | Direct |
Sesen Bio, Inc. | Director | Stock Option | 65K | Jun 22, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TRVN | TREVENA INC | Oct 8, 2024 | 5 | -$2.68K | 4 | Oct 10, 2024 | Acting CEO, Director |
TRVN | TREVENA INC | Dec 14, 2023 | 3 | $282K | 4 | Dec 15, 2023 | President & CEO |
TRVN | TREVENA INC | Dec 2, 2023 | 3 | -$7.1K | 4 | Dec 5, 2023 | President & CEO |
TRVN | TREVENA INC | Jan 6, 2023 | 1 | $0 | 4 | Jan 6, 2023 | President & CEO, Director |
TRVN | TREVENA INC | Dec 17, 2022 | 1 | -$2.08K | 4 | Dec 20, 2022 | President & CEO |
TRVN | TREVENA INC | Dec 2, 2022 | 1 | -$12.2K | 4 | Dec 6, 2022 | President & CEO, Director |
NBRV | Nabriva Therapeutics plc | Aug 1, 2022 | 1 | -$1.49K | 4 | Aug 3, 2022 | Director |
CARM | Sesen Bio, Inc. | Jun 22, 2022 | 2 | $0 | 4 | Jun 24, 2022 | Director |
TRVN | TREVENA INC | Dec 17, 2021 | 1 | -$23.5K | 4 | Dec 21, 2021 | President & CEO, Director |
TRVN | TREVENA INC | Dec 6, 2021 | 1 | -$60.8K | 4 | Dec 8, 2021 | President & CEO, Director |
TRVN | TREVENA INC | Dec 2, 2021 | 1 | $0 | 4 | Dec 3, 2021 | President & CEO, Director |
NBRV | Nabriva Therapeutics plc | Aug 2, 2021 | 1 | -$932 | 4 | Aug 4, 2021 | Director |
NBRV | Nabriva Therapeutics plc | Jul 28, 2021 | 2 | $0 | 4 | Jul 30, 2021 | Director |
TRVN | TREVENA INC | Jun 28, 2021 | 1 | $101K | 4 | Jun 28, 2021 | President & CEO, Director |